Research Article
Calprotectin and Calgranulin C as Biomarkers of Pancreatic Tumors: Baseline Levels and Level Changes after Surgery
Table 2
Baseline characteristics of patients with malignant and benign tumors and healthy controls and their comparisons.
| ||||||||||||||||||||||||||||||||||||||||
: difference between cohorts with benign and malignant tumors; M: male; F: female; N.s.: not significant. and . |